Literature DB >> 33600489

Pre-existing heterosubtypic immunity provides a barrier to airborne transmission of influenza viruses.

Valerie Le Sage1, Jennifer E Jones1, Karen A Kormuth1, William J Fitzsimmons2, Eric Nturibi1, Gabriella H Padovani1, Claudia P Arevalo3, Andrea J French1, Annika J Avery1, Richard Manivanh1, Elizabeth E McGrady1, Amar R Bhagwat1, Adam S Lauring2,4, Scott E Hensley3, Seema S Lakdawala1,5.   

Abstract

Human-to-human transmission of influenza viruses is a serious public health threat, yet the precise role of immunity from previous infections on the susceptibility to airborne infection is still unknown. Using the ferret model, we examined the roles of exposure duration and heterosubtypic immunity on influenza transmission. We demonstrate that a 48 hour exposure is sufficient for efficient transmission of H1N1 and H3N2 viruses. To test pre-existing immunity, a gap of 8-12 weeks between primary and secondary infections was imposed to reduce innate responses and ensure robust infection of donor animals with heterosubtypic viruses. We found that pre-existing H3N2 immunity did not significantly block transmission of the 2009 H1N1pandemic (H1N1pdm09) virus to immune animals. Surprisingly, airborne transmission of seasonal H3N2 influenza strains was abrogated in recipient animals with H1N1pdm09 pre-existing immunity. This protection from natural infection with H3N2 virus was independent of neutralizing antibodies. Pre-existing immunity with influenza B virus did not block H3N2 virus transmission, indicating that the protection was likely driven by the adaptive immune response. We demonstrate that pre-existing immunity can impact susceptibility to heterologous influenza virus strains, and implicate a novel correlate of protection that can limit the spread of respiratory pathogens through the air.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33600489      PMCID: PMC7891786          DOI: 10.1371/journal.ppat.1009273

Source DB:  PubMed          Journal:  PLoS Pathog        ISSN: 1553-7366            Impact factor:   6.823


  53 in total

1.  Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies.

Authors:  Florian Krammer; Natalie Pica; Rong Hai; Irina Margine; Peter Palese
Journal:  J Virol       Date:  2013-04-10       Impact factor: 5.103

2.  Ferrets as a transmission model for influenza: sequence changes in HA1 of type A (H3N2) virus.

Authors:  M L Herlocher; S Elias; R Truscon; S Harrison; D Mindell; C Simon; A S Monto
Journal:  J Infect Dis       Date:  2001-08-02       Impact factor: 5.226

3.  Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity antibodies in the absence of neutralizing antibodies.

Authors:  Sinthujan Jegaskanda; Emma R Job; Marit Kramski; Karen Laurie; Gamze Isitman; Robert de Rose; Wendy R Winnall; Ivan Stratov; Andrew G Brooks; Patrick C Reading; Stephen J Kent
Journal:  J Immunol       Date:  2013-01-14       Impact factor: 5.422

4.  H3N2 influenza virus infection induces broadly reactive hemagglutinin stalk antibodies in humans and mice.

Authors:  Irina Margine; Rong Hai; Randy A Albrecht; Gerlinde Obermoser; A Carson Harrod; Jacques Banchereau; Karolina Palucka; Adolfo García-Sastre; Peter Palese; John J Treanor; Florian Krammer
Journal:  J Virol       Date:  2013-02-13       Impact factor: 5.103

5.  Antibody-dependent cellular cytotoxicity is associated with control of pandemic H1N1 influenza virus infection of macaques.

Authors:  Sinthujan Jegaskanda; Jason T Weinfurter; Thomas C Friedrich; Stephen J Kent
Journal:  J Virol       Date:  2013-03-06       Impact factor: 5.103

6.  Blocking interhost transmission of influenza virus by vaccination in the guinea pig model.

Authors:  Anice C Lowen; John Steel; Samira Mubareka; Elena Carnero; Adolfo García-Sastre; Peter Palese
Journal:  J Virol       Date:  2009-01-19       Impact factor: 5.103

7.  Neutralizing antibodies against previously encountered influenza virus strains increase over time: a longitudinal analysis.

Authors:  Matthew S Miller; Thomas J Gardner; Florian Krammer; Lauren C Aguado; Domenico Tortorella; Christopher F Basler; Peter Palese
Journal:  Sci Transl Med       Date:  2013-08-14       Impact factor: 17.956

8.  Sequential Infection in Ferrets with Antigenically Distinct Seasonal H1N1 Influenza Viruses Boosts Hemagglutinin Stalk-Specific Antibodies.

Authors:  Greg A Kirchenbaum; Donald M Carter; Ted M Ross
Journal:  J Virol       Date:  2015-11-11       Impact factor: 5.103

9.  Age-specific differences in the dynamics of protective immunity to influenza.

Authors:  Sylvia Ranjeva; Rahul Subramanian; Vicky J Fang; Gabriel M Leung; Dennis K M Ip; Ranawaka A P M Perera; J S Malik Peiris; Benjamin J Cowling; Sarah Cobey
Journal:  Nat Commun       Date:  2019-04-10       Impact factor: 14.919

10.  Non-neutralizing Antibodies Directed at Conservative Influenza Antigens.

Authors:  E S Sedova; D N Scherbinin; A A Lysenko; S V Alekseeva; E A Artemova; M M Shmarov
Journal:  Acta Naturae       Date:  2019 Oct-Dec       Impact factor: 1.845

View more
  7 in total

1.  Parsing Immune Correlates of Protection Against SARS-CoV-2 from Biomedical Literature.

Authors:  Sydney L Foote; Sara Jones; Jane Lockmuller; Liliana Brown; Joseph Breen; Anupama Gururaj
Journal:  AMIA Annu Symp Proc       Date:  2022-02-21

2.  Bivalent H1 and H3 COBRA Recombinant Hemagglutinin Vaccines Elicit Seroprotective Antibodies against H1N1 and H3N2 Influenza Viruses from 2009 to 2019.

Authors:  James D Allen; Ted M Ross
Journal:  J Virol       Date:  2022-03-15       Impact factor: 6.549

3.  Cell-Culture Adaptation of H3N2 Influenza Virus Impacts Acid Stability and Reduces Airborne Transmission in Ferret Model.

Authors:  Valerie Le Sage; Karen A Kormuth; Eric Nturibi; Juhye M Lee; Sheila A Frizzell; Michael M Myerburg; Jesse D Bloom; Seema S Lakdawala
Journal:  Viruses       Date:  2021-04-21       Impact factor: 5.048

4.  Prior infection with antigenically heterologous low pathogenic avian influenza viruses interferes with the lethality of the H5 highly pathogenic strain in domestic ducks.

Authors:  Kosuke Soda; Maya Yamane; Chiharu Hidaka; Kozue Miura; Trang T H Ung; Hang L K Nguyen; Hiroshi Ito; Mai Q LE; Toshihiro Ito
Journal:  J Vet Med Sci       Date:  2021-11-04       Impact factor: 1.267

5.  Secondary infection with Streptococcus pneumoniae decreases influenza virus replication and is linked to severe disease.

Authors:  Karina Mueller Brown; Valerie Le Sage; Andrea J French; Jennifer E Jones; Gabriella H Padovani; Annika J Avery; Stacey Schultz-Cherry; Jason W Rosch; N Luisa Hiller; Seema S Lakdawala
Journal:  FEMS Microbes       Date:  2022-03-04

Review 6.  Animal Models for Influenza Research: Strengths and Weaknesses.

Authors:  Thi-Quyen Nguyen; Rare Rollon; Young-Ki Choi
Journal:  Viruses       Date:  2021-05-28       Impact factor: 5.048

7.  Evaluation of Next-Generation H3 Influenza Vaccines in Ferrets Pre-Immune to Historical H3N2 Viruses.

Authors:  James D Allen; Ted M Ross
Journal:  Front Immunol       Date:  2021-08-12       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.